|1.||Papadimitriou, Evangelia: 16 articles (02/2016 - 06/2005)|
|2.||Courty, José: 16 articles (08/2015 - 08/2002)|
|3.||Keller, Martin B: 11 articles (12/2013 - 01/2002)|
|4.||Delbé, Jean: 10 articles (08/2015 - 08/2002)|
|5.||Deuel, Thomas F: 9 articles (02/2009 - 01/2002)|
|6.||Mikelis, Constantinos: 8 articles (07/2013 - 06/2007)|
|7.||Hamma-Kourbali, Yamina: 7 articles (08/2015 - 11/2007)|
|8.||Perez-Pinera, Pablo: 7 articles (02/2009 - 05/2006)|
|9.||Herradón, Gonzalo: 6 articles (09/2015 - 04/2009)|
|10.||Katsoris, Panagiotis: 6 articles (11/2012 - 06/2005)|
09/01/2002 - "Subjects in this study experienced decreased pain and anxiety with the harp intervention, and slight reductions in physiologic variable values. "
02/01/1998 - "Repeated measures analysis of variance showed a significant interaction between time and group in the distress of pain on Day 1, but not on Day 2, and in pain sensation on Day 2, but not Day 1. Subjects from Taiwan were similar to subjects in a previous study in the United States in their liking for the music, and in reports of the helpfulness of the music for pain sensation and distress, but fewer Taiwanese found the music calming, and they had different choices: more chose harp music and fewer chose jazz than subjects in the U.S. "
05/01/2014 - "The results demonstrate the effectiveness of using concomitant Healing Touch and Healing Harp to significantly reduce moderate to severe pain and anxiety in this patient population. "
05/01/2014 - "Impact of healing touch with healing harp on inpatient acute care pain: a retrospective analysis."
07/27/2013 - "Other arguments, such as donor safety and pain, should determine the choice between HARP and LDN."
|2.||Lung Neoplasms (Lung Cancer)
03/18/2002 - "Our study suggests that pleiotrophin may be an early indicator of lung cancer and might be of use in monitoring the efficacy of therapy, which needs to be confirmed by larger studies."
03/18/2002 - "In most of the lung cancer patients (81%), we found serum levels of pleiotrophin above those of control subjects (P<0.001). "
11/14/1997 - "Our findings suggest that HB-GAM may serve as a marker for SCLC cell lines and that it may function as a paracrine growth factor in human lung cancer. "
09/30/2010 - "In this study, we show that menin-regulated A549 lung cancer cell migration, which was mediated by growth factor pleiotrophin (PTN) and its cell surface receptor, protein tyrosine phosphatase beta/zeta (RPTP β/ζ). "
03/18/2002 - "Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients."
01/01/2004 - "In this study, we measured the levels of HARP and MK in plasma samples from 77 cancer patients. "
09/01/2014 - "SR angiography with a HARP receiver provides high sensitivity and spatial resolution and makes it possible to diagnose metastatic lung tumors of less than 1 mm in size by focusing on differences in the clearance times of contrast material."
09/01/2014 - "To compare left ventricular circumferential and radial strain by feature tracking vs. harmonic phase imaging analysis (HARP) in pediatric cancer survivors. "
02/15/2011 - "Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia."
01/01/2010 - "A Pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ."
|5.||Class 5 Receptor-Like Protein Tyrosine Phosphatases
|6.||Small Interfering RNA (siRNA)
|7.||Aspirin (Acetylsalicylic Acid)
|8.||Angiogenesis Inducing Agents (Angiogenesis Factor)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Complementary Therapies (Alternative Medicine)
|4.||Intraocular Lenses (Intraocular Lens)